Medicine and Dentistry
Human Immunodeficiency Virus
100%
Infection
47%
Cells
42%
Lymphatic Tissue
40%
Patient
33%
Antiretroviral Therapy
33%
Human Immunodeficiency Virus Infection
29%
T Cell
25%
Therapeutic Procedure
24%
T-Helper Cell
24%
Human Immunodeficiency Virus 1
23%
Combination Therapy
19%
Disease
18%
Acute HIV Infection
15%
Virus
14%
Fibrosis
13%
Tissues
13%
Simian Immunodeficiency Virus
12%
Blood
12%
Lymph Node
12%
Depletion
11%
Human Immunodeficiency Virus 1 Infection
11%
Plasma
11%
Collagen
10%
Cell Population
10%
Herpes Simplex Virus
10%
Immune Reconstitution
9%
Herpes Simplex Virus 2
8%
Cell Count
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Cytotoxic T-Cell
7%
Virus Infection
7%
RNA
7%
Herpes Genitalis
7%
Virus Replication
7%
COVID-19
7%
Primary Infection
6%
Gastrointestinal Tract
6%
Losartan
6%
Randomized Clinical Trial
6%
Inguinal Lymph Node
6%
Gut
6%
Inflammation
6%
Highly Active Antiretroviral Therapy
6%
Treatment Interruption
6%
B Cell
6%
Placebo
6%
Man
5%
Antibody
5%
Host
5%
Immunology and Microbiology
Human Immunodeficiency Virus
94%
Human Immunodeficiency Virus 1
68%
Tissues
40%
Cells
40%
Human Immunodeficiency Virus Infection
37%
Lymphoid Tissue
27%
Immunity
26%
T Cell
25%
Herpes Simplex Virus
22%
Simian Immunodeficiency Virus
19%
Blood Plasma
18%
Viral Replication
16%
T-Helper Cell
14%
Viral Disease
13%
Virus
12%
CD4
12%
Herpes Simplex Virus 2
11%
CD4 Lymphocyte Count
9%
Gene
9%
T Cell Depletion
9%
Host
8%
Gastrointestinal Tract
8%
Immune Response
8%
Cytotoxic T-Cell
7%
B Cell
7%
Viremia
7%
Gene Expression
7%
Regulatory T Cell
6%
Time
6%
Virus Reactivation
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Vaccine Efficacy
6%
Follicular Dendritic Cells
5%
Genital Herpes
5%
Sample
5%
Immune Reconstitution
5%
Development
5%
Reduction (Chemistry)
5%
Immunosuppressive Drug
5%
Interleukin 7
5%
Monospecific Antibody
5%
Viral Load
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
45%
Infection
18%
Herpes Simplex Virus
14%
Virus
12%
Human Immunodeficiency Virus 1
11%
Human Immunodeficiency Virus Infection
10%
Aciclovir
9%
Virus Infection
9%
Indinavir
8%
Blindness
6%
Genital Herpes
6%
Losartan
6%
Drug
6%
Lamivudine Plus Zidovudine
6%
Placebo
6%
Pharmacokinetics
5%
Human Immunodeficiency Virus 1 Infection
5%
